NR4A1 and breast cancer: Survival differences between African American and white patients with breast cancer have often been attributed to more advanced stage at diagnosis [39], unfavorable tumor biology features such as hormone receptor-negative disease [19] or triple-negative disease [40], lower SES [5,41], and inferior use of adjuvant treatments [9,42-46].